Rainbow Beds: Profit Pivot Ahead?

Rainbow Children's Medicare, India's top pediatric and perinatal hospital chain, runs about 2,300 beds across 22 hospitals and 5 clinics in 9 cities. Right now, only 47% of these beds are occupied, down from over 53% last year, due to recent additions like 80 beds in Rajahmundry and plans for 900 more by FY29, including 450 in Delhi-NCR. Shareholder Benefits from Expansion This low occupancy hurts short-term profits as fixed costs spread over fewer patients, causing EBITDA margins to dip slightly to 33% in Q3 FY26 despite 9% YoY EBITDA growth to Rs 1.5 billion. Revenue rose 12% YoY to Rs 4.5 billion, boosted by 9% higher ARPOB at Rs 58,400 per day from better case mix and shorter stays. Yet, it's highly valuable for long-term shareholders. Analysts see a profit inflection as new beds ramp up, projecting occupancy to 52-54% by FY26-28, driving 17-18% revenue CAGR and 19% EBITDA CAGR from FY26-28. The asset-light hub-spoke model ensures quick break-evens, high ROCE over 30%, and strong cash flows without debt, sustaining top margins. Risks and Upside Balance Expansion outpaces demand temporarily, pressuring stocks sector-wide through 2026, but Rainbow's specialty focus (70% pediatrics) gives pricing power and less competition. Healthy balance sheet supports Rs 900 crore capex internally. Overall, patient shareholders benefit as capacity unlocks massive growth in underserved child/mother care post-Covid, turning low occupancy into leveraged profits and superior returns.